| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRANSPROCEED.2004.12.121 |
| P698 | PubMed publication ID | 15848544 |
| P2093 | author name string | B D Kahan | |
| R Knight | |||
| C T Van Buren | |||
| C Benavides | |||
| K H Mahmoud | |||
| C Barcenas | |||
| P2860 | cites work | Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management | Q33332820 |
| Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling | Q42814573 | ||
| Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients | Q44168474 | ||
| Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis | Q44527275 | ||
| Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study | Q44527287 | ||
| The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function | Q44536893 | ||
| Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation | Q44549982 | ||
| Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus | Q44967971 | ||
| Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study | Q57943257 | ||
| The effect of in vivo T helper and T suppressor lymphocyte depletion on wound healing | Q69296714 | ||
| Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group | Q73253906 | ||
| The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation | Q79907943 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 822-826 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Transplantation Proceedings | Q7834825 |
| P1476 | title | Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients? | |
| P478 | volume | 37 |
| Q38068519 | Adverse events associated with mTOR inhibitors |
| Q37881022 | Incisional hernia after simultaneous pancreas kidney tranplantation: a single-center experience from Budapest |
| Q26785848 | Lymphatic disorders after renal transplantation: new insights for an old complication |
| Q58766893 | Optimal surgical management in kidney and pancreas transplantation to minimise wound complications: A systematic review and meta-analysis |
| Q33871855 | Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications |
| Q36889289 | Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients |
| Q37873950 | Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment |
| Q51595119 | Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus. |
| Q38962103 | mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions |
Search more.